The Florida Pharmacy Association and others are suing to restore patient access to Medicaid pharmacy providers.
FDA is ridding the market of single-ingredient oxycodone capsules that are being distributed without an FDA-approved application.
U.S. Senate and House negotiations on the Food Safety and Innovation Act (S. 3187) have resulted in the proposal that 26 synthetic drugs be newly regulated under the Controlled Substances Act.
A recent study indicated that the cost of diabetes treatment could be reduced if physicians prescribed more generics
Experts gave tips on helping prevent crimes focused on retail pharmacy during Protect Your Pharmacy Week in late April
Connecticut's recently enacted law legalizing medical marijuana includes language ensuring that pharmacists who follow state law will be protected from prosecution
A number of pharmacy groups are protesting an amendment changing the classification of hydrocodone-containing pain relief products from Schedule III to the more restrictive Schedule II under the Controlled Substances Act.
Omnicell's new mobile medication dispensing system features a 12-drawer locked cart with two-dimensional bar-code capabilities for patient identification and medication administration.
After settling a lawsuit with the State of New York over the sale of expired products, CVS is involved in a similar suit initiated by the State of Connecticut.
The DeLoitte Center for Health Solutions has released a study projecting a slow-down in growth of retail pharmacy clinics across the United States in the next two years.